Combination therapy for hepatitis C virus with heat-shock protein 90 inhibitor 17-AAG and proteasome inhibitor MG132.

Source:http://linkedlifedata.com/resource/pubmed/id/20231781

Download in:

View as

General Info

PMID
20231781